Learn about the ISN’s work in advocacy below.
ISN Joins Stakeholder Consultation on the Development of the WHO Global Diabetes Compact
Professor Ifeoma Ulasi, University of Nigeria, ISN Advocacy Working Group member, and Paul Laffin, ISN Advocacy Director, participated in the WHO Stakeholder Consultation on the Development of the WHO Global Diabetes Compact on October 14, 2020. The WHO Global Diabetes Compact, to be launched in April 2021, builds on the Global Hearts Initiative to focus...
ISN to Contribute to WHO Regional Committee Meetings
The ISN continues to strengthen its collaboration with the World Health Organization during the COVID-19 pandemic. In 2020, besides attending the World Health Assembly, the ISN will participate in the 72nd Session of the Regional Committee of WHO for the Americas and the 71st session of the World Health Organization Regional Committee for the Western...
Help Empower Kidney Patients: CELEBRATE World Kidney Day 2021
World Kidney Day (WKD) 2021 takes place on Thursday, March 11. The 2021 campaign will focus on, “Kidney Health for Everyone, Everywhere - Living Well with Kidney Disease.” Initiatives will concentrate on raising awareness of effective symptom-management to improve patients’ quality of life and encouraging patient self-empowerment to ensure that people with kidney diseases can...
The ISN Presents Evidence to the UK Committee on the Science of COVID-19
Professor Donal O’Donoghue, Chair of the ISN’s Advocacy Working Group, was among a distinguished panel of experts who gave evidence at the House of Lords Science and Technology Select Committee hearing on the Science of COVID-19 in the UK. Presenting at the beginning of the virtual session on Tuesday, September 15, Professor O’Donoghue outlined the...